Clinical Nutrition and Metabolism

We aim to increase our knowledge about the role of diet and nutrition in the prevention and treatment of cardiometabolic diseases, including type 2 diabetes, fatty liver (MASLD), obesity and cardiovascular disease.


The overarching goal of our research is to understand how the food we eat affects our cardiometabolic health, focusing on type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease. We have extensive experience conducting both randomized clinical dietary studies and prospective population studies, with a specific emphasis on fatty acids and dietary biomarkers. Our research aims to improve preventive strategies and contribute to new knowledge on how various dietary components and patterns can be used to optimize the treatment of conditions like NAFLD and type 2 diabetes. Precision nutrition is also an area where we have ongoing research with significant clinical potential.

Picture of the Clinic Nutrition and Metabolism Research groupZoom image

Members of the CNM research group

Current within the group

  • Mohammed Bajahzer defended his thesis on January 24, 2024, on a dissertation about how carbohydrates affect the fatty acid profile in the blood.
  • The NAFLDiet study has finished, and the analyses of the results are underway. You can read more about the NAFL study here.
  • Recruitment for the NORDHEART study is planned to begin in the first half of 2024. You can read more about the NORDHEART study here.
  • We are organizing the 41st International Symposium of Diabetes and Nutrition on June 27-30, 2024.

Group members

Research leader: Ulf Risérus
Group members: Fredrik Rosqvist, Michael Fridén, Andréa Flores, Tommy Cederholm, David Iggman, Bengt Vessby, Hans-Erik Johansson, Mohammed Bajahzer, Wulf Becker, Ulf Holmbäck, Sigvard Sobestiansky, Matti Marklund, Sara Younes, Lillemor Källström
Further members can be found in the University directory.